Semaglutide (Ozempic) in Australia — Patient Information
General patient information about semaglutide, a prescription-only medicine in Australia. TGA-approved indication, PBS context for type 2 diabetes, and AHPRA-prescriber requirements. Not an advertisement and not medical advice.
Important information for Australian consumers
Semaglutide is a prescription-only (Schedule 4) medicine in Australia. Australian regulations restrict the advertising of prescription medicines to consumers, so this page is general patient information about Semaglutide and the kind of consultation involved in being prescribed it — not an advertisement, not an offer of sale, and not medical advice. Speak with an AHPRA-registered prescriber to discuss whether Semaglutide is clinically appropriate for you. Always read the label and follow the directions for use.
About Semaglutide in Australia
Semaglutide is a prescription-only medicine in Australia. Under the brand name Ozempic it is TGA-approved for the management of type 2 diabetes — not for weight management. Australian regulations restrict advertising of prescription medicines to consumers, so this page is general patient information; it is not an advertisement and not an invitation to seek Ozempic for weight loss. Off-label prescribing of any medicine is a clinical decision made by an AHPRA-registered prescriber and is not endorsed by the manufacturer or the TGA. Discuss any treatment route with a registered prescriber.
TGA-approved indication
Ozempic (semaglutide) is TGA-approved in Australia for the management of type 2 diabetes. The TGA has specifically stated that promoting semaglutide for weight loss is not permitted in Australia. Wegovy is a separate semaglutide product TGA-approved for weight management.
What to discuss with an AHPRA-registered prescriber
- The TGA-approved indication for the medicine and whether it applies to your clinical circumstances.
- PBS eligibility under the relevant indication, including the streamlined or authority requirements.
- Monitoring and follow-up requirements during treatment.
- Alternatives that are TGA-approved for the condition you are seeking treatment for.
- Side effects, interactions and what to do if you experience them.
Service-level cost components
Private prescription care in Australia generally involves the following cost components. The medicine itself is priced by the dispensing pharmacy — ask the prescriber and pharmacy for a written breakdown before paying.
Consultation fee
GP and specialist consultation fees vary. Medicare rebates may apply where a Medicare item number is used.
Prescription / clinical assessment
May be included in the consultation or charged separately.
Pharmacy dispensing
Private pen pricing is set by the dispensing pharmacy. PBS-subsidised dispensing applies only where the patient meets the PBS criteria.
Follow-up reviews
Diabetes care typically involves regular review with the prescriber and may include blood tests.
PBS and Medicare context
PBS subsidy for semaglutide (Ozempic) applies to eligible patients with type 2 diabetes who meet the current PBS criteria. Outside that indication the cost is generally paid privately. Medicare may rebate part of the consultation cost where a Medicare item number is used. Check the current PBS schedule at pbs.gov.au.
Australia hub
Related Australian healthcare information
Sources and updates
How this page is sourced
Sources
- TGA medicine information
- PBS schedule (pbs.gov.au)
- AHPRA Register of Practitioners
Methodology: This page is general patient information about an Australian-regulated medicine. Brand-name cost tables, provider × price tables and Offer/AggregateOffer schema are not displayed for compliance with the TGA Therapeutic Goods Advertising Code.
Caveat: This page is not medical advice and is not a recommendation to use any prescription medicine. Speak with an AHPRA-registered prescriber.
FAQs
What is Ozempic approved for in Australia?
Ozempic (semaglutide) is TGA-approved for the management of type 2 diabetes. It is not TGA-approved for weight management; the TGA has stated that promoting Ozempic for weight loss is not permitted in Australia.
Can I get Ozempic on the PBS?
PBS subsidy for Ozempic applies to eligible patients with type 2 diabetes who meet the current PBS criteria. Eligibility is decided by an AHPRA-registered prescriber using current PBS rules at pbs.gov.au.
Why does the TGA restrict promotion of Ozempic for weight loss?
Ozempic is not TGA-approved for weight management. Australian rules require that promotion of a prescription medicine match its approved indication and not encourage off-label use to consumers.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide. Ozempic is approved for type 2 diabetes; Wegovy is a separate product approved for weight management. Suitability of either is a clinical decision for an AHPRA-registered prescriber.
How do I verify an Australian prescriber?
Verify the practitioner on the AHPRA Register of Practitioners at ahpra.gov.au before any consultation or prescription.